Astria Therapeutics (ATXS) Q1 2023 Earnings

May 11Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-1.01
-0.81
-0.6
-0.4

Details

Expected EPS
-0.55
Actual EPS
-0.4
Surprise EPS
0.15
Surprise Percent
+27.27%

Description

⁨Astria Therapeutics⁩ (⁦ATXS⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts